Fate Therapeutics Inc FATE Balance Sheet

Income Statement

Quarter End	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	749.35M	705.56M	630.34M	584.76M	543.79M	506.22M	569.89M	528.82M
Total Current Assets	535.33M	502.07M	437.89M	392.18M	364.17M	331.54M	394.38M	319.39M
Cash and Equivalents	82.09M	61.33M	42.02M	46.8M	33.33M	41.87M	121.32M	36.92M
Total Non-Current Assets	214.02M	313.51M	192.45M	192.58M	179.61M	271.51M	175.52M	209.43M
Total Liabilities	231.35M	221.62M	152.86M	147M	141.01M	137.8M	143.78M	131.84M
Total Current Liabilities	103.94M	114.05M	48.65M	44.69M	41.33M	39.09M	45.37M	34.79M
Total Non-Current Liabilities	128.21M	107.57M	104.21M	102.31M	99.68M	98.71M	98.41M	97.04M
Common Equity	100k	100k	101k	102k	102k	102k	117k	117k
Retained Earnings	-994.44M	-1.05B	-1.07B	-1.12B	-1.17B	-1.21B	-1.26B	-1.3B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	95.05M	105.29M	213.03M	302.27M	622.46M	921.46M	705.56M	506.22M
Total Current Assets	93.32M	102.6M	205.2M	227.09M	494.32M	633.41M	502.07M	331.54M
Cash and Equivalents	88.61M	88.95M	190.51M	99.81M	167.35M	133.58M	61.33M	41.87M
Total Non-Current Assets	73.15M	77.19M	160.47M	244.76M	384.45M	678.84M	483.94M	368.42M
Total Liabilities	21.89M	28.1M	52.56M	57.52M	238.01M	242.62M	221.62M	137.8M
Total Current Liabilities	15.19M	11.05M	27.26M	27.81M	85.56M	81.28M	114.05M	39.09M
Total Non-Current Liabilities	9.21M	31.86M	39.15M	30.41M	153.25M	162.13M	107.57M	98.71M
Total Equity	73.15M	77.19M	160.47M	244.76M	384.45M	678.84M	483.94M	368.42M
Common Equity	44k	56k	68k	79k	91k	99k	100k	102k
Retained Earnings	-175.85M	-218.8M	-285.4M	-383.55M	-556.93M	-769.08M	-1.05B	-1.21B